풀전트 제네틱스(FLGT)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $21.69 (-0.73%), 시가총액 $0.46B, 52주 최저~최고 $13.79 ~ $30.85.
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencaps
풀전트 제네틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
풀전트 제네틱스의 현재 주가는 $21.69 (-0.73%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
풀전트 제네틱스의 시가총액은 약 $0.46B입니다.
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutio